InnoCare Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SEHK:9969 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
17 Jul 24	SellHK$220,448,792	Vivo Capital, LLC	Company	48,880,000	HK$4.51
06 Jun 24	SellHK$1,201,761	Goldman Sachs Group, Investment Banking and Securities Investments	Company	259,000	HK$4.64
12 Apr 24	SellHK$1,520,923	Chan Pang Kee	Individual	310,000	HK$4.91
11 Apr 24	SellHK$106,192,748	Loyal Valley Capital	Company	21,417,157	HK$4.96
10 Apr 24	SellHK$362,040	Chan Pang Kee	Individual	56,000	HK$6.46
12 Mar 24	SellHK$5,830,166	GIC Private Limited	Company	1,173,000	HK$4.97

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 9969?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	83,384,879	4.73%
Hedge Funds	208,671,222	11.8%
Individual Insiders	376,294,621	21.3%
Institutions	415,712,614	23.6%
General Public	678,503,866	38.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 58.58% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
11.8%	HHLR Advisors, Ltd.	208,671,222	HK$1.5b	0%	2.16%
8.92%	Chan Pang Kee	157,141,425	HK$1.1b	0%	no data
6.46%	Renbin Zhao	113,839,593	HK$816.8m	-21.3%	no data
5.73%	Jisong Cui	100,951,416	HK$724.3m	0%	no data
4.83%	Vivo Capital, LLC	85,053,118	HK$610.3m	-30.9%	5.58%
2.96%	Loyal Valley Capital	52,120,614	HK$374.0m	0%	5.94%
2.15%	Strausberg Group Limited	37,856,875	HK$271.6m	0%	no data
2.07%	Golden Autumn Group Limited	36,552,483	HK$262.3m	0%	no data
1.87%	GIC Private Limited	32,935,484	HK$236.3m	0%	0.05%
1.61%	The Vanguard Group, Inc.	28,373,196	HK$203.6m	0.14%	no data
1.16%	Penghua Fund Management Co., Ltd.	20,533,594	HK$147.3m	0%	0.2%
1.13%	Wanjia Asset Management Co., Ltd.	20,000,000	HK$143.5m	0%	0.36%
1.09%	Bosera Asset Management Co., Ltd.	19,174,566	HK$137.6m	0%	0.06%
1.05%	GF Fund Management Co., Ltd.	18,512,000	HK$132.8m	0%	0.03%
0.81%	China Universal Asset Management Company Ltd.	14,315,034	HK$102.7m	0%	0.06%
0.72%	E Fund Management Co., Ltd.	12,748,467	HK$91.5m	0%	0.02%
0.54%	Goldman Sachs Group, Investment Banking and Securities Investments	9,587,019	HK$68.8m	0%	no data
0.51%	Guangzhou Development District Holding Group Limited	8,975,521	HK$64.4m	0%	no data
0.51%	BlackRock, Inc.	8,958,000	HK$64.3m	1.54%	no data
0.5%	China Fund Management Co., Ltd.	8,900,000	HK$63.9m	0%	1.46%
0.49%	China International Capital Corporation Hong Kong Asset Management Limited	8,690,091	HK$62.4m	0%	0.58%
0.47%	China Asset Management Co. Ltd.	8,253,311	HK$59.2m	-1.13%	0.01%
0.42%	RBC Global Asset Management Inc.	7,467,321	HK$53.6m	0%	no data
0.4%	Bank of China Investment Management Co., Ltd.	7,042,762	HK$50.5m	0%	0.26%
0.34%	Fidelity International Ltd	5,939,889	HK$42.6m	0.54%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/31 17:47
End of Day Share Price	2024/12/31 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

InnoCare Pharma Limited is covered by 17 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Peng Zou	China International Capital Corporation Limited
Tan Huan Gan	Citic Securities Co., Ltd.
Shitong Han	Citic Securities Co., Ltd.